• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在冯·希佩尔-林道病患者的多个显微镜下可见的透明细胞肾病变中检测到VHL基因的等位基因缺失。

Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.

作者信息

Lubensky I A, Gnarra J R, Bertheau P, Walther M M, Linehan W M, Zhuang Z

机构信息

Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892, USA.

出版信息

Am J Pathol. 1996 Dec;149(6):2089-94.

PMID:8952541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1865348/
Abstract

Patients with von Hippel-Lindau (VHL) disease develop a spectrum of bilateral clear-cell renal lesions including cysts and renal cell carcinomas (RCCs). VHL gene deletions have been previously reported in VHL-associated macroscopic RCC. Although histological analysis suggests that microscopic cystic lesions in the VHL patients may represent precursors of the RCC, there is at present no direct molecular evidence of their relationship. To investigate the relationship between cystic lesions and RCC, 26 microdissected archival renal lesions from two VHL disease patients were studied for loss of heterozygosity at the VHL gene locus using polymerase chain reaction single-strand conformation polymorphism analysis. The renal lesions included 2 benign cysts, 5 atypical cysts, 5 microscopic RCCs in situ, 5 cysts lined by a single layer of cells, in which RCCs in situ were developing, and 2 microscopic and 7 macroscopic RCCs. Except for a single benign cyst, 25 of 26 renal lesions showed nonrandom allelic loss of the VHL gene. In either of the 2 patients, the same VHL allele was deleted in all of the lesions tested, indicating loss of the wild-type allele and retention of the inherited, mutated VHL allele. The results suggest that all clear-cell lesions in the VHL kidney represent neoplasms and that the loss of the VHL gene occurs early in their development. Atypical and benign cysts most likely represent the initial phenotype in malignant transformation to the RCC.

摘要

患有冯·希佩尔-林道(VHL)病的患者会出现一系列双侧透明细胞肾病变,包括囊肿和肾细胞癌(RCC)。先前已有报道VHL相关的肉眼可见的RCC中存在VHL基因缺失。尽管组织学分析表明VHL病患者的微小囊性病变可能是RCC的前体,但目前尚无它们之间关系的直接分子证据。为了研究囊性病变与RCC之间的关系,利用聚合酶链反应单链构象多态性分析,对两名VHL病患者的26个经显微切割的存档肾病变进行了VHL基因位点杂合性缺失研究。肾病变包括2个良性囊肿、5个非典型囊肿、5个原位微小RCC、5个由单层细胞衬里且有原位RCC正在形成的囊肿,以及2个微小RCC和7个肉眼可见的RCC。除了一个单一的良性囊肿外,26个肾病变中有25个显示VHL基因的非随机等位基因缺失。在这两名患者中的任何一名中,所有检测的病变中均缺失相同的VHL等位基因,表明野生型等位基因缺失而保留了遗传的、突变的VHL等位基因。结果表明,VHL肾中的所有透明细胞病变均代表肿瘤,且VHL基因缺失在其发展早期就已发生。非典型囊肿和良性囊肿很可能代表了向RCC恶性转化的初始表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/814a/1865348/8d4b4f45c435/amjpathol00036-0298-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/814a/1865348/ef206b3b811f/amjpathol00036-0296-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/814a/1865348/55a979640f14/amjpathol00036-0296-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/814a/1865348/d35de844948f/amjpathol00036-0297-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/814a/1865348/8d4b4f45c435/amjpathol00036-0298-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/814a/1865348/ef206b3b811f/amjpathol00036-0296-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/814a/1865348/55a979640f14/amjpathol00036-0296-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/814a/1865348/d35de844948f/amjpathol00036-0297-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/814a/1865348/8d4b4f45c435/amjpathol00036-0298-a.jpg

相似文献

1
Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.在冯·希佩尔-林道病患者的多个显微镜下可见的透明细胞肾病变中检测到VHL基因的等位基因缺失。
Am J Pathol. 1996 Dec;149(6):2089-94.
2
Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.与终末期肾病/获得性肾囊肿病相关的透明细胞肾细胞癌中的体细胞性希佩尔-林道病基因突变。
Genes Chromosomes Cancer. 2002 Dec;35(4):359-64. doi: 10.1002/gcc.10123.
3
Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.原发性肾细胞癌中冯·希佩尔-林道(VHL)肿瘤抑制基因的失活及3号染色体短臂的等位基因缺失:透明细胞肾肿瘤发生中存在不依赖VHL途径的证据
Genes Chromosomes Cancer. 1998 Jul;22(3):200-9. doi: 10.1002/(sici)1098-2264(199807)22:3<200::aid-gcc5>3.0.co;2-#.
4
Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.伴有肾脏病变的冯·希佩尔-林道家族的基因型-表型相关性
Hum Mutat. 2004 Sep;24(3):215-24. doi: 10.1002/humu.20082.
5
Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.在透明细胞和乳头状肾细胞癌中,RASSF1A 3p21.3肿瘤抑制基因的表观遗传失活。
Cancer Res. 2001 Oct 1;61(19):7277-81.
6
Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.结节性硬化症患者透明细胞肾细胞癌中冯·希佩尔-林道基因的突变分析。
Mod Pathol. 2002 Mar;15(3):205-10. doi: 10.1038/modpathol.3880517.
7
Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.通过表达阵列分析鉴定细胞周期蛋白D1和其他与希佩尔-林道肿瘤抑制基因相关的新靶点,并研究细胞周期蛋白D1基因型作为希佩尔-林道病的修饰因子。
Cancer Res. 2002 Jul 1;62(13):3803-11.
8
Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization.通过荧光原位杂交检测肾细胞癌中冯·希佩尔-林道基因缺失的肿瘤内异质性
Cancer Res. 1998 Jun 1;58(11):2304-9.
9
VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease.单个肾小管上皮细胞和肾小管囊肿中的 VHL 基因突变:von Hippel-Lindau 病中透明细胞肾细胞癌囊性依赖进展途径的进一步证据。
Am J Surg Pathol. 2010 Jun;34(6):806-15. doi: 10.1097/PAS.0b013e3181ddf54d.
10
Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene.人肾细胞癌中HNF1α功能丧失:VHL基因频繁突变,而非HNF1α基因。
Mol Carcinog. 1999 Apr;24(4):305-14.

引用本文的文献

1
Molecular chaperones: Guardians of tumor suppressor stability and function.分子伴侣:肿瘤抑制因子稳定性和功能的守护者。
Oncotarget. 2024 Oct 1;15:679-696. doi: 10.18632/oncotarget.28653.
2
von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology.von Hippel-Lindau 与缺氧诱导因子在肾细胞癌生物学中的核心地位。
Hematol Oncol Clin North Am. 2023 Oct;37(5):809-825. doi: 10.1016/j.hoc.2023.04.011. Epub 2023 Jun 1.
3
The Extracellular Matrix Environment of Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌的细胞外基质环境

本文引用的文献

1
Identification of the von Hippel-Lindau disease tumor suppressor gene.冯·希佩尔-林道病肿瘤抑制基因的鉴定。
Science. 1993 May 28;260(5112):1317-20. doi: 10.1126/science.8493574.
2
Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications.与冯·希佩尔-林道病相关的家族性肾细胞癌肾脏病理学特征:临床及分子遗传学意义
J Urol. 1995 Jan;153(1):22-6. doi: 10.1097/00005392-199501000-00009.
3
Evaluation of color Doppler intraoperative ultrasound in parenchymal sparing renal surgery.
Cancers (Basel). 2022 Aug 23;14(17):4072. doi: 10.3390/cancers14174072.
4
Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma.鉴定 HGD 和 GSTZ1 作为代谢重编程在肾透明细胞癌中的生物标志物。
Int J Mol Sci. 2022 Apr 21;23(9):4583. doi: 10.3390/ijms23094583.
5
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.透明细胞肾细胞癌的发生机制及致死机制。
Nat Rev Nephrol. 2021 Apr;17(4):245-261. doi: 10.1038/s41581-020-00359-2. Epub 2020 Nov 3.
6
Von Hippel-Lindau Disease: Current Challenges and Future Prospects.冯·希佩尔-林道病:当前挑战与未来展望
Onco Targets Ther. 2020 Jun 16;13:5669-5690. doi: 10.2147/OTT.S190753. eCollection 2020.
7
Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma.单细胞基因分析验证了透明细胞肾细胞癌患者循环癌细胞的细胞病理学鉴定。
Oncotarget. 2018 Apr 13;9(28):20058-20074. doi: 10.18632/oncotarget.25102.
8
The HIF and other quandaries in VHL disease.VHL 病中的 HIF 和其他难题。
Oncogene. 2018 Jan 11;37(2):139-147. doi: 10.1038/onc.2017.338. Epub 2017 Sep 18.
9
Loss of vhl in the zebrafish pronephros recapitulates early stages of human clear cell renal cell carcinoma.斑马鱼前肾中VHL的缺失重现了人类透明细胞肾细胞癌的早期阶段。
Dis Model Mech. 2016 Aug 1;9(8):873-84. doi: 10.1242/dmm.024380.
10
PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men.PI3K/AKT/mTOR信号通路在大鼠和人类肾远端小管的糖原积累及肿瘤发生发展中起主要致病作用。
Oncotarget. 2015 May 30;6(15):13036-48. doi: 10.18632/oncotarget.3675.
实质保留性肾手术中彩色多普勒术中超声的评估
J Urol. 1994 Dec;152(6 Pt 1):1984-7. doi: 10.1016/s0022-5347(17)32285-1.
4
Mutations of the VHL tumour suppressor gene in renal carcinoma.肾癌中VHL肿瘤抑制基因的突变
Nat Genet. 1994 May;7(1):85-90. doi: 10.1038/ng0594-85.
5
A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size.一种用于对大小小于1毫米的病变中特定细胞群体进行存档DNA分析的显微切割技术。
Am J Pathol. 1995 Mar;146(3):620-5.
6
Parenchymal sparing surgery in patients with hereditary renal cell carcinoma.遗传性肾细胞癌患者的保留肾实质手术
J Urol. 1995 Mar;153(3 Pt 2):913-6.
7
Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.冯·希佩尔-林道病肿瘤抑制基因的种系突变:与表型的相关性。
Hum Mutat. 1995;5(1):66-75. doi: 10.1002/humu.1380050109.
8
Nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease.针对冯·希佩尔-林道病肾细胞癌的保留肾单位手术
J Urol. 1995 Dec;154(6):2016-9.
9
Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications.冯·希佩尔-林道病、散发性肾细胞癌及无肾脏疾病患者大体正常肾实质中微观病变的患病率:临床意义
J Urol. 1995 Dec;154(6):2010-4; discussion 2014-5.
10
Prognostic significance of morphologic parameters in renal cell carcinoma.肾细胞癌形态学参数的预后意义
Am J Surg Pathol. 1982 Oct;6(7):655-63. doi: 10.1097/00000478-198210000-00007.